Ciclesonide Impacts Clinicopathological Features of Pediatric Eosinophilic Esophagitis

Study authors examined whether CIC can effectively induce or maintain histologic remission and clinical improvement in patients with EoE as well as its potential for adverse effects.

Diagnostic Dilemma Clinic for Undiagnosed Medical Conditions in Children

Our experts help get answers for families who have struggled to find a diagnosis or have unexplained symptoms.

Burn Center

We specialize in treating pediatric burn injuries through expert care, decades of experience and comprehensive clinics.

MRI Findings Following Button Battery Ingestion

According this this study, MRI can be a valuable tool for guiding clinical management of patients who ingested button batteries. Learn more.

2022

Anterior and Posterior Fontanelle Closures

Learn about anterior and posterior fontanelle closures, bulging and sunken fontanelles, and special considerations for premature babies from our experts.

Demystifying a Novel Disease

Through whole-genome sequencing, immunologists identified a novel genetic mutation and unlocked information critical to treating a patient’s rare disease –– Pneumocystis jirovecii pneumonia.

Prenatal Whole-Exome Sequencing to Diagnose Children with Rare Diseases

Researchers and specialists from across the Anschutz Medical Campus have come together to form one of the nation’s first fetal precision medicine boards to leverage whole-exome sequencing for families facing an uncertain future with rare disease.

Preventing Pediatric Cardiac Arrest in the CICU Through the Cardiac Arrest Reduction and Excellence (CARE) Program

Researchers from CICU implement the CARE program to improve resuscitation response and reduce the incidence of cardiac arrest in pediatric patients.

Designing the Largest and Most Diverse Pediatric COVID-19 Vaccine Trial

In 2021, Children’s Hospital Colorado played a central role in the effort to clinically validate Pfizer’s COVID-19 vaccine for children, enrolling 252 participants altogether. It wasn’t just the largest study group, at 11% of the study population worldwide. It was also, very intentionally, the most diverse.